阶段角作为在接受血液透析的患者中,sarcopenic肥胖症的新型指标
Linghong Cheng1,2, Liyang Chang1, Ruchun Yang1
1Department of Nephrology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Frontiers in nutrition
|November 24, 2025
概括
阶段角 (PhA) 是检测血液透析患者的骨肥胖症 (SO) 的可靠指标. 这项研究确定了用于查SO的特定PhA切割值,有助于早期干预.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 老年病的医生 老年病的医生
- 营养科学 营养科学
背景情况:
- 在血液透析 (HD) 患者中,相角 (PhA) 和肉骨肥胖 (SO) 之间的关系还不清楚.
- 慢性脏病患者中,SO是越来越令人担忧的慢性脏病需要HD.
研究的目的:
- 为了研究PHA和SO在HD患者之间的关联.
- 为了在这个人群中预测SO,建立PhA截止值.
主要方法:
- 这是一项涉及436名HD患者的横截面研究.
- 用生物电阻分析测量相角.
- 使用修订的亚洲萨科佩尼亚工作组标准结合体脂百分比诊断的sarcopenic肥胖症.
- 使用多项逻辑回归和ROC曲线分析.
主要成果:
- 119名参与者 (27.3%) 被诊断为SO.
- 调整后的分析显示,PhA与较低的SO风险 (OR=0.098) 有关.
- PhA表现出优异的SO预测能力 (AUC:0.841男性,0.836女性) 具有特定的截止值.
结论:
- 在HD患者中检测SO时,相角是准确的.
- PhA可以作为一种有价值的查工具,用于早期识别面临SO风险的个人.
更多相关视频
相关概念视频
Hemodialysis III: Nursing Management
701
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
701
Peritoneal Dialysis III: Nursing Management
620
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
620
Chronic Kidney Disease III: Interprofessional Care
326
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
326
Hemodialysis II: Procedure and Complications
583
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
583
Hemodialysis I: Introduction
1.2K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.2K
Chronic Kidney Disease II: Clinical Manifestations
531
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
531


